Bernardo Cortese
Latest contributions
Current indications for DCB in de novo lesions
18 May 2023 – From EuroPCR 2023
If you are interested in learning more about drug-coated balloon angioplasty in de novo disease, don't miss this informative session, which incorporates real-life cases. The session begins with a comprehensive review of the top five papers published in the past year, focusing on this topic. Additionally,...
Going down the road of coronary artery disease treatment: sirolimus-coated balloon and DES + DCB stent platform
16 May 2023 – From EuroPCR 2023
What better way to talk about sirolimus-coated balloons than with real-life clinical cases? In this session, study the case of a 78-year-old man with crescendo angina and inferior wall ischaemia, or a 48-year-old woman with crescendo angina, type 2 DM and anterior wall hypokinesia with mild...
Treatment of calcified lesions
07 Oct 2022 – From AICT-AsiaPCR 2022
Consider a 66-year-old man, hypertensive and diabetic for 10 years, with history of recurrent substernal chest pain and exertional dyspnea, who presented with easy fatigability and shortness of breath, or a 72-year-old man on dialysis who presented with STEMI and severe calcified stenosis of LAD/DI bifurcation,...
Sirolimus coated balloon: expanding the scope of coronary artery disease treatment
07 Oct 2022 – From AICT-ASIAPCR 2022
Consult this session to understand the technology and scientific evidence of the novel sirolimus drug-coated balloon, to learn its utility for PCI in a variety of lesion and patient subsets and to understand the evidence and outcomes in real-world patients.
Rotational atherectomy for the treatment of calcified coronary lesion - Session with LIVE case
07 Oct 2022 – From AICT-AsiaPCR 2022
Let's see how this 80-year-old female patient with hypertension, hyperlipidaemia, diabetes mellitus, chronic kidney disease, history of ischaemic heart disease (2018) and NSTEMI (August 2022), currently asymptomatic but mainly homebound, was treated LIVE, and learn more about the treatment of calcified coronary lesion.
Clinical cases - Coronary interventions - Session 5
07 Oct 2022 – From AICT-AsiaPCR 2022
What's new in treatment of stent failure - a closer look at stent restenosis and thrombosis
This session shows cases from daily practice that illustrate the problems of stent failure from a general perspective. It allows for a better understanding of the mechanisms of stent restenosis & thrombosis on the one hand, and the role of DCBs on the other.
EuroPCR 2022 Hotlines / Late-Breaking Trials in Drug-eluting balloons: U-REDUCE STENT, HYPER, IMPROVED-CTO, and more!
19 May 2022 – From EuroPCR 2022
Find out more about various studies & registries in drug-eluting balloons! A Sirolimus-coated balloon with micro-reservoir technology in coronary lesions, utilisation of DEB guided by post-PCI pressure gradient, DEB in combination with DES in the treatment of diffuse coronary artery disease,DEB for in-stent restenosis and plaque...
The current role of paclitaxel DCB in PCI
18 May 2022 – From EuroPCR 2022
Thanks to the different interventions of this EuroPCR 2022 session, understand the role of paclitaxel DCB in modern era interventional cardiology, the differences, and advantages versus DES, the role of blended therapies in CLS, and learn how to correctly prepare the lesion and obtain the best from this technology on...
Sirolimus coated balloon and coronary artery disease: expanding the treatment indications
17 May 2022 – From EuroPCR 2022
Through a case presentation, as well as upcoming studies and rationale for the Food and Drug Administration, the aim of this EuroPCR 2022 session is to help you answer the following questions: how can the use of a sirolimus-coated DCB be expanded in new and challenging treatment indications? Why is...
Sustained Limus release, redefining indications for drug-eluting balloons
20 May 2021 – From EuroPCR 2021
Watch this session presented by Bernardo Cortese, Kambis Mashayekhi, Jonas Häner and Tuomas Rissanen in order to understand how sustained Limus release technology can broaden DEB indications, to learn how SELUTION SLR sustained Limus DEB performs in daily clinical practice, and to know more about the importance of sustained Limus release technology...
MagicTouch sirolimus coated balloon continues to be the choice of treatment for CAD
19 May 2021 – From EuroPCR 2021
Watch this session presented by Antonio Colombo, Aloke Finn, Sandeep Basavarajaiah, Gianluca Caiazzo and Bernardo Cortese in order to know where to use a DCB in today's clinical practice, to learn about real-world case-based experience and interesting data presentation from various registries and clinical studies, and to understand the technology...
The future of PCI seems bright - The MagicTouch sirolimus-coated balloon
18 May 2021 – From EuroPCR 2021
Watch this session presented by Antonio Colombo, Bernardo Cortese and Sandeep Basavarajaiah in order to understand the strategy behind using a DCB as a proper solution for CAD and the result and potential of using a Sirolimus DCB in coronary intervention, as well as to get insights into real...
Sirolimus-coated balloons, an appraisal on its potential advantages over paclitaxel
26 Jun 2020 – From PCR e-Course 2020
Watch this session if you want to learn and understand how and where to use a Sirolimus DCB in current practice, to see clinical evidences and results for the treatment of Patients with Sirolimus DCB and to see the potential advantages of using the Sirolimus over...
Abstracts on stent & scaffolds - PCR e-Course 2020
25 Jun 2020 – From PCR e-Course 2020
View a selection of abstracts from PCR e-Course 2020 on the topic of Stents & scaffolds:
- 12-month follow-up results of the first cohort of the BIOSOLVE-IV registry
- The effects of shockwave lithotripsy on DES
- 5-year data of the drug-eluting absorbable metal scaffold in BIOSOLVE-II
- Bailout stenting post drug coated balloons;...
Sirolimus-eluting DCB: update from the Eastbourne study
In this short video, Bernado Cortese (Italy) describes the interim analysis of the Eastbourne study, which is evaluating the performance of a sirolimus-eluting DCB for the treatment of any type of coronary lesion, including native vessel disease and in-stent restenosis. The Eastbourne registry is enrolling patients...
New trials in coronary imaging and physiology
23 May 2019 – From EuroPCR 2019
Consult this session to learn all about the new trials and studies in coronary imaging and physiology: FFR-Search, ROCK II, HAWKEYE, and more!
Transforming DCB strategy: sirolimus-coated balloon with Nanolute technology
21 May 2019 – From EuroPCR 2019
Consult this session on DCB strategy to learn more about the use of sirolimus-coated balloon with Nanolute technology, and to understand its benefits and its future applications in coronary interventions, thanks to the insight from pre-clinical evaluation, various clinical cases and FDA study.
Trials and registries - Clinical outcomes after interventions with drug-coated balloons
21 May 2019 – From EuroPCR 2019
Consult this session to learn more about the results of the latest trials and registries regarding the clinical outcomes after interventions with drug-coated balloons: SCAAR, BASKET-SMALL 2, EASTBOURNE, and more!